Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven)

Anesthesiology. 2003 Jun;98(6):1513-5. doi: 10.1097/00000542-200306000-00034.

Authors

Kenichi A Tanaka¹, Amr A Waly, William A Cooper, Jerrold H Levy

Affiliation

¹ Department of Anesthesiology, Emory University School of Medicine and Division of Cardiothoracic Anesthesiology and Critical Care, Emory Healthcare, Atlanta, Georgia 30322, USA.

PMID: 12766668
DOI: 10.1097/00000542-200306000-00034

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Blood Loss, Surgical*
Factor VIIa / therapeutic use*
Female
HIV Seropositivity
Heart Valve Prosthesis Implantation
Hemorrhage / drug therapy*
Hemostatics / therapeutic use*
Humans
Intraoperative Complications / drug therapy*
Jehovah's Witnesses*
Male
Middle Aged
Mitral Valve / surgery
Postoperative Hemorrhage / drug therapy*
Recombinant Proteins / therapeutic use

Substances

Hemostatics
Recombinant Proteins
Factor VIIa